Results 21 to 30 of about 160,899 (200)

NK1 receptor antagonists versus other antiemetics in the prevention of postoperative nausea and vomiting following laparoscopic surgical procedures: a systematic review and meta-analysis

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2022
A systematic electronic search of MEDLINE, EMBASE, and CINAHL databases aimed at comparing neurokinin-1 receptor antagonists with other antiemetics in their prevention of postoperative nausea and vomiting in adult patients undergoing laparoscopic surgery
John Cavaye   +5 more
doaj   +1 more source

The Contribution of Phospholipase C in Vomiting in the Least Shrew (Cryptotis Parva) Model of Emesis

open access: yesFrontiers in Pharmacology, 2021
Gq and Gβγ protein-dependent phospholipase C (PLC) activation is extensively involved in G protein-coupled receptor (GPCR)-mediated signaling pathways which are implicated in a wide range of physiological and pathological events.
Weixia Zhong, Nissar A. Darmani
doaj   +1 more source

Substance P selectively decreases paired pulse depression in the rat hippocampal slice

open access: yesBMC Neuroscience, 2005
Background Although being widespread in the hippocampus, the role tachykinins play in synaptic transmission is unclear. The effect of substance P on field potentials evoked by stimulation of the Schaffer collateral-commissural fibres and recorded from ...
Davies Stephen N, Wease Kerrie N
doaj   +1 more source

Neurokinin-1 receptor activation in globus pallidus

open access: yesFrontiers in Neuroscience, 2009
The undecapeptide substance P has been demonstrated to modulate neuronal activity in a number of brain regions by acting on neurokinin-1 receptors. Anatomical studies revealed a moderate level of neurokinin-1 receptor in rat globus pallidus. To determine
Lei Chen   +4 more
doaj   +1 more source

Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults

open access: yesExpert Review of Clinical Pharmacology, 2019
Introduction: The addition of neurokinin-1 receptor antagonists (NK1RAs) to standard prophylaxis of 5-hydroxytryptamine-3 RA (5-HT3RA) plus dexamethasone more effectively prevents chemotherapy-induced nausea and vomiting (CINV) associated with highly and
M. Karthaus   +3 more
semanticscholar   +1 more source

Autocrine regulation of human sperm motility by tachykinins

open access: yesReproductive Biology and Endocrinology, 2010
Background We examined the presence and function of tachykinins and the tachykinin-degrading enzymes neprilysin (NEP) and neprilysin-2 (NEP2) in human spermatozoa.
Pinto Francisco M   +7 more
doaj   +1 more source

Efficacy of Vestipitant, A Neurokinin-1 Receptor Antagonist, in Primary Insomnia [PDF]

open access: yesSleep, 2013
Investigate the hypnotic effects of repeated doses of neurokinin-1 receptor antagonist, vestipitant, in primary insomnia.Randomized, double-blind, placebo-controlled 28-day parallel-group study.Eleven sleep centers in Germany.One hundred sixty-one patients with primary insomnia.Patients received vestipitant (15 mg) or placebo for 28 days; 2-night ...
Emiliangelo, Ratti   +10 more
openaire   +2 more sources

Neurokinin 1 receptor antagonists exhibit peripheral effects in prurigo nodularis including reduced ERK1/2 activation

open access: yesJournal of the European Academy of Dermatology and Venereology, 2019
Aprepitant is a neurokinin 1 receptor (NK1R) antagonist used for its antipruritic properties in dermatoses and systemic diseases. The mode of action is still unclear.
Konstantin Agelopoulos   +8 more
semanticscholar   +1 more source

NK-1 Receptor Antagonists and Pruritus: Review of Current Literature

open access: yesDermatology and Therapy, 2019
The discovery of the first neurokinin 1 (NK-1) receptor antagonist was a turning point in the prevention of chemotherapy-induced nausea and vomiting. The NK-1 antagonists are a novel class of drugs that possess antidepressant, anxiolytic, and antiemetic ...
Marcelina Pojawa-Gołąb   +2 more
doaj   +1 more source

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients

open access: yesAl-Mustansiriyah Journal of Pharmaceutical Sciences, 2023
Background:Chemotherapy-caused nausea and vomiting is a health problem in cancer patients. Olanzapine is used with serotonin receptor antagonists plus dexamethasone post Neurokinin 1 receptor antagonists as the antiemetic.
Ghufran salah ahmed   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy